Dow Up 0.11% Nasdaq Up 0.50%

OXiGENE, Inc. (OXGN)

-NasdaqCM
2.38 Up 0.10(4.39%) Aug 29, 4:00PM EDT
Prev Close:2.28
Open:2.30
Bid:2.33 x 1600
Ask:2.50 x 2500
1y Target Est:6.00
Beta:2.85
Next Earnings Date: 4-Nov-14OXGN Earnings announcement
Day's Range:2.26 - 2.39
52wk Range:1.96 - 5.40
Volume:523,000
Avg Vol (3m):384,145
Market Cap:49.28M
P/E (ttm):N/A
EPS (ttm):-3.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OXGN

Comparison

Symbol% ChgMkt Cap
OXGNUp 4.39%49.28M
AZNUp 2.38%96.00B
SNY 0.00%143.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):496.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.95
Quarterly EPS Est (Sep-14) :-0.23
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OXiGENE, Inc., a clinical-stage biopharmaceutical company, develops therapeutics primarily to treat cancer. The company focuses on developing vascular disrupting agents (VDAs) that disrupt abnormal blood vessels associated with solid tumor progres... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback